Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum QLT INC T.QLT

"QLT Inc is a biotechnology company conducts development and commercialization of ocular products that address the unmet medical needs of patients and clinicians."

TSX:QLT - Post Discussion

QLT INC > Since AKAO made a 100% profit, check QLT
View:
Post by Miner1967 on Jun 03, 2016 2:59pm

Since AKAO made a 100% profit, check QLT

I proposed AKAO afew days ago but due to a jump from 2.85 to 5.70, I sold just above 5.

Another flying unde rthe radar  biotech you should check is QLT.TO, traded as QLTI in NASDAQ.

QLTI trades around 1.55 USD while its cash is 2.00 USD per share..!

Three institutionals have bought shares of QLTI lately, Tiger Legatus Capital Management, LLC, BVF INC, and Healthcare Value Capital, LLC.

The company has a management team which was very active in the recent past in M&A.

It has a pipeline with its lead product ready for Phase III. Mark thar it is an orphan drug designation awarded product.

With more than 2 USD cash, buying shares until this level means that you buy all the other QLT assets for free...

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities